ATHA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 114980 min ago

@ $3.22

Wydano: 14 vas. 2024 @ 16:30

Zwrot: -39.13%

Poprzedni sygnał: vas. 13 - 16:30

Poprzedni sygnał: Kupno

Zwrot: 1.26 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation...

Stats
Dzisiejszy wolumen	147 921
Średni wolumen	350 266
Kapitalizacja rynkowa	75.12M
EPS	$0 ( 2024-03-28 )
Następna data zysków	( $-0.800 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.630
ATR14	$0.00500 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	San Martin Javier	Buy	400 000	Stock Option (Right to Buy)
2024-04-15	San Martin Javier	Buy	0
2024-02-15	Litton Mark James	Buy	650 000	Stock Option (Right to Buy)
2024-02-14	Worthington Mark	Buy	220 000	Stock Option (Right to Buy)
2024-02-14	Church Kevin	Buy	220 000	Stock Option (Right to Buy)

INSIDER POWER
98.61
Last 99 transactions
Buy: 6 665 546 \| Sell: 65 252

Wolumen Korelacja

Długi: -0.06 (neutral)

Krótki: -0.63 (weak negative)

Signal:(46.827) Neutral

Athira Pharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje
XERS	0.9
SGBX	0.898
VNET	0.893
SRTS	0.888
ABST	0.885
CNDT	0.883
RYTM	0.883
XENE	0.882
FREQ	0.882
WDAY	0.88

10 Najbardziej negatywne korelacje
RDUS	-0.883
TLMD	-0.879
CRWD	-0.879
LVO	-0.878
TYHT	-0.877
ICON	-0.873
ZGNX	-0.873
PAE	-0.873
PETV	-0.869
GOODM	-0.868

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Athira Pharma, Inc. Korelacja - Waluta/Towar

0.43
( neutral )

0.38
( neutral )

0.00
( neutral )

0.29
( neutral )

0.00
( neutral )

-0.39
( neutral )

Athira Pharma, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-969 000 (0.00 %)
EPS:	$-3.09

FY	2023
Przychody:	$0
Zysk brutto:	$-969 000 (0.00 %)
EPS:	$-3.09

FY	2022
Przychody:	$0
Zysk brutto:	$-1.05M (0.00 %)
EPS:	$-2.31

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-4.58

Financial Reports:

No articles found.

Athira Pharma, Inc.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.

Aktualne aktualizacje dla Athira Pharma, Inc. [ATHA]

Upcoming Earnings Alert